Moving toward clinical development, the researchers demonstrated efficient delivery of mRNA mitochondrial base editors using ...

The FDA's biologics chief issued a stern rebuke of the Florida Surgeon General's latest letter criticizing the agency's oversight of mRNA COVID vaccines, calling it "misleading" and equating its ...

In a step toward treating mitochondrial diseases, researchers in the Netherlands have successfully edited harmful mutations ...

In a step toward treating mitochondrial diseases, researchers in the Netherlands have successfully edited harmful mutations ...

These cells came from a person with Gitelman-like syndrome, a disorder linked to mitochondrial dysfunction. The correction ...

The personalized CRISPR treatment could be the future of gene therapy, but hurdles remain before everyone has access.

Readers respond to articles about the Trump administration’s assault on science. Also: The coming military parade in Washington.

In a step toward treating mitochondrial diseases, researchers in the Netherlands have successfully edited harmful mutations ...

RNA in control. By uncovering RNA's previously unknown function to repair DNA damage, our findings show how RNA may directly contribute to the stability and evolution of the genome.

A more effective vaccine technology may be on the horizon. In a new study in mice, researchers from the University of ...

mRNA research holds promise beyond COVID-19 — it could lead to breakthroughs on treating tuberculosis, pancreatic cancer, and more.

The translation of mRNA begins with the formation of a complex on the mRNA (Figure 4). First, three initiation factor proteins (known as IF1, IF2, and IF3) bind to the small subunit of the ribosome.